DeepSeek R1’s rise shows AI’s promise and peril — cost-effective yet risky. Privacy, bias and security flaws demand responsible AI now.
You might also be interested in reading Apyx Medical outlines $50M–$52M 2025 revenue targets as AYON presales surpass expectations and China launch advances.